Short Term Analysis of New Single-Piece Aspheric Diffractive Trifocal Intraocular Lens Implantation

Purpose. Evaluation of short-term (up to 9 months) results of new one-piece aspherical diffractive trifocal intraocular lens implantation. Patients and Methods. A prospective, open-label study included 65 patients (100 eyes) with presbyopia, who received cataract extraction with the implantation of...

Full description

Bibliographic Details
Main Authors: K. B. Pershin, N. F. Pashinova, M. M. Konovalova, A. Yu. Tsygankov, M. E. Konovalov, N. E. Temirov
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2019-03-01
Series:Oftalʹmologiâ
Subjects:
Online Access:https://www.ophthalmojournal.com/opht/article/view/851
_version_ 1797875427000188928
author K. B. Pershin
N. F. Pashinova
M. M. Konovalova
A. Yu. Tsygankov
M. E. Konovalov
N. E. Temirov
author_facet K. B. Pershin
N. F. Pashinova
M. M. Konovalova
A. Yu. Tsygankov
M. E. Konovalov
N. E. Temirov
author_sort K. B. Pershin
collection DOAJ
description Purpose. Evaluation of short-term (up to 9 months) results of new one-piece aspherical diffractive trifocal intraocular lens implantation. Patients and Methods. A prospective, open-label study included 65 patients (100 eyes) with presbyopia, who received cataract extraction with the implantation of a new IOL AcrySof PanOptix® trifocal. The average age of the patients was 60.0 ± 12.1 years. 35 patients underwent bilateral correction with multifocal IOLs, and 30 had a monolateral correction. In 21 % (n = 21) cases, femtolaser support of cataract extraction was performed. In 9 eyes (9 %) the primary posterior capsulorhexis was performed. The range of optical power of implanted IOLs was 13 to 30 D. The follow-up period was from 6 to 9 (6.8 ± 0.9) months. Results. On the 1 day after the MIOL implantation, an UCIVA increase was from 0.22 ± 0.19 to 0.76 ± 0.23 (p < 0.05), at follow-up to 6 months up to 0.85 ± 0.22. One day after surgery, the UCIVA increased from 0.23 ± 0.19 to 0.7 ± 0.25 (p < 0.05), with following raise up to 0.84 ± 0.24 in the maximum follow-up period of 6 months. UCFVA in the preoperative period was 0.27 ± 0.23, with an increase to 0.78 ± 0.23 (p < 0.05) for 1 day and 0.93 ± 0.18 at 6 months. The BCNVA increase was from 0.56 ± 0.25 before surgery to 0.8 ± 0.19 on the 1st day after cataract removal (p < 0.05) and 0.98 ± 0.16 at the 6 months follow-up period. Similar data (0.58 ± 0.29, 0.82 ± 0.21, and 0.95 ± 0.14) was noted for BCIVA. An BCFVA increase was from 0.71 ± 0.28 in the preoperative period to 1.0 ± 0.04 (p < 0.05) after 6 months. The primary endpoint of the study (BCFVA = 1.0) in the group was achieved in 83 % of cases (n = 83). The effect of glare was noted in 17 patients (26.1 %), halo in 9 (13.8 %), driving difficulties in 6 (9.2 %). The overwhelming majority of patients (96.9 %) rated the result of the operation as “excellent” (n = 51, 78.5 %) and “good” (n = 14, 21.5 %). Conclusion. Implantation of the examined IOL is associated with a high efficiency for near, intermediate distance and far vision correction. A new trifocal IOL may be recommended for use in clinical practice. Further comparative studies including other multifocal IOLs are needed to determine the indications and contraindications for its implantation.
first_indexed 2024-04-10T01:47:28Z
format Article
id doaj.art-17b5fb4afb874e0ca487616eda282d25
institution Directory Open Access Journal
issn 1816-5095
2500-0845
language Russian
last_indexed 2024-04-10T01:47:28Z
publishDate 2019-03-01
publisher Ophthalmology Publishing Group
record_format Article
series Oftalʹmologiâ
spelling doaj.art-17b5fb4afb874e0ca487616eda282d252023-03-13T09:08:39ZrusOphthalmology Publishing GroupOftalʹmologiâ1816-50952500-08452019-03-01161192510.18008/1816-5095-2019-1-19-25487Short Term Analysis of New Single-Piece Aspheric Diffractive Trifocal Intraocular Lens ImplantationK. B. Pershin0N. F. Pashinova1M. M. Konovalova2A. Yu. Tsygankov3M. E. Konovalov4N. E. Temirov5Офтальмологический центр «Эксимер»Офтальмологический центр «Эксимер»Офтальмологический центр КоноваловаОфтальмологический центр «Эксимер»Офтальмологический центр КоноваловаОфтальмологический комплекс «Леге Артис»Purpose. Evaluation of short-term (up to 9 months) results of new one-piece aspherical diffractive trifocal intraocular lens implantation. Patients and Methods. A prospective, open-label study included 65 patients (100 eyes) with presbyopia, who received cataract extraction with the implantation of a new IOL AcrySof PanOptix® trifocal. The average age of the patients was 60.0 ± 12.1 years. 35 patients underwent bilateral correction with multifocal IOLs, and 30 had a monolateral correction. In 21 % (n = 21) cases, femtolaser support of cataract extraction was performed. In 9 eyes (9 %) the primary posterior capsulorhexis was performed. The range of optical power of implanted IOLs was 13 to 30 D. The follow-up period was from 6 to 9 (6.8 ± 0.9) months. Results. On the 1 day after the MIOL implantation, an UCIVA increase was from 0.22 ± 0.19 to 0.76 ± 0.23 (p < 0.05), at follow-up to 6 months up to 0.85 ± 0.22. One day after surgery, the UCIVA increased from 0.23 ± 0.19 to 0.7 ± 0.25 (p < 0.05), with following raise up to 0.84 ± 0.24 in the maximum follow-up period of 6 months. UCFVA in the preoperative period was 0.27 ± 0.23, with an increase to 0.78 ± 0.23 (p < 0.05) for 1 day and 0.93 ± 0.18 at 6 months. The BCNVA increase was from 0.56 ± 0.25 before surgery to 0.8 ± 0.19 on the 1st day after cataract removal (p < 0.05) and 0.98 ± 0.16 at the 6 months follow-up period. Similar data (0.58 ± 0.29, 0.82 ± 0.21, and 0.95 ± 0.14) was noted for BCIVA. An BCFVA increase was from 0.71 ± 0.28 in the preoperative period to 1.0 ± 0.04 (p < 0.05) after 6 months. The primary endpoint of the study (BCFVA = 1.0) in the group was achieved in 83 % of cases (n = 83). The effect of glare was noted in 17 patients (26.1 %), halo in 9 (13.8 %), driving difficulties in 6 (9.2 %). The overwhelming majority of patients (96.9 %) rated the result of the operation as “excellent” (n = 51, 78.5 %) and “good” (n = 14, 21.5 %). Conclusion. Implantation of the examined IOL is associated with a high efficiency for near, intermediate distance and far vision correction. A new trifocal IOL may be recommended for use in clinical practice. Further comparative studies including other multifocal IOLs are needed to determine the indications and contraindications for its implantation.https://www.ophthalmojournal.com/opht/article/view/851катарактамультифокальная иолтрифокальная иолпресбиопияpanoptix
spellingShingle K. B. Pershin
N. F. Pashinova
M. M. Konovalova
A. Yu. Tsygankov
M. E. Konovalov
N. E. Temirov
Short Term Analysis of New Single-Piece Aspheric Diffractive Trifocal Intraocular Lens Implantation
Oftalʹmologiâ
катаракта
мультифокальная иол
трифокальная иол
пресбиопия
panoptix
title Short Term Analysis of New Single-Piece Aspheric Diffractive Trifocal Intraocular Lens Implantation
title_full Short Term Analysis of New Single-Piece Aspheric Diffractive Trifocal Intraocular Lens Implantation
title_fullStr Short Term Analysis of New Single-Piece Aspheric Diffractive Trifocal Intraocular Lens Implantation
title_full_unstemmed Short Term Analysis of New Single-Piece Aspheric Diffractive Trifocal Intraocular Lens Implantation
title_short Short Term Analysis of New Single-Piece Aspheric Diffractive Trifocal Intraocular Lens Implantation
title_sort short term analysis of new single piece aspheric diffractive trifocal intraocular lens implantation
topic катаракта
мультифокальная иол
трифокальная иол
пресбиопия
panoptix
url https://www.ophthalmojournal.com/opht/article/view/851
work_keys_str_mv AT kbpershin shorttermanalysisofnewsinglepieceasphericdiffractivetrifocalintraocularlensimplantation
AT nfpashinova shorttermanalysisofnewsinglepieceasphericdiffractivetrifocalintraocularlensimplantation
AT mmkonovalova shorttermanalysisofnewsinglepieceasphericdiffractivetrifocalintraocularlensimplantation
AT ayutsygankov shorttermanalysisofnewsinglepieceasphericdiffractivetrifocalintraocularlensimplantation
AT mekonovalov shorttermanalysisofnewsinglepieceasphericdiffractivetrifocalintraocularlensimplantation
AT netemirov shorttermanalysisofnewsinglepieceasphericdiffractivetrifocalintraocularlensimplantation